Selectivity of Class-III Antiarrhythmic Action of Clofilium in Guinea Pig Ventricular Myocytes
- 1 March 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 27 (3) , 401-410
- https://doi.org/10.1097/00005344-199603000-00013
Abstract
Clofilium is an antiarrhythmic agent with a supposedly predominant class-III action which is related to impairment of K+ channel function. We investigated membrane currents in cardiac myocytes isolated from guinea pig ventricle to evaluate the selectivity of action of clofilium on K+ currents. For measurement of action potentials or membrane currents, the single electrode patch clamp technique was applied in current- or voltage-clamp mode, respectively. Clofilium (30 mu M) irreversibly prolonged the action potential duration in guinea pig myocytes. In contrast, the concomitant reduction in plateau phase was completely reversible. The delayed rectifier K+ current Ikappa, was reduced. The rapidly activating component of Ikappa, which has been defined by its sensitivity to the compound E-4031, was also reduced by clofilium. The inward rectifier was slightly inhibited by the drug. Clofilium reversibly reduced L-type Ca2+ current. Sodium current was inhibited in a use-dependent manner. This effect was not reversible but proceeded after washout of the compound. Therefore, clofilium affects both inward and outward currents in mammalian cardiac myocytes in a similar concentration range. The effects on multiple membrane currents may contribute to the antiarrhythmic action of the drug.Keywords
This publication has 27 references indexed in Scilit:
- Cellular Electrophysiological Effects of the Class III Antiarrhythmic Agents Sematilide and Clofilium on Rabbit Atrial TissuesJournal of Cardiovascular Pharmacology, 1991
- Measurement and block of potassium channel currents in the heart: Importance of channel typeDrug Development Research, 1990
- Monophasic Action Potentials During Reentrant Atrial Flutter in the Dog: Effects of Clofilium and AcetylcholineJournal of Cardiovascular Pharmacology, 1989
- Effects of Pharmacologic Agents on Induced Atrial Flutter in Dogs with Right Atrial EnlargementJournal of Cardiovascular Pharmacology, 1986
- Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine modelsEuropean Journal of Pharmacology, 1985
- The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heartAmerican Heart Journal, 1985
- Dose-ranging studies of clofilium, an antiarrhythmic quaternary ammoniumClinical Pharmacology & Therapeutics, 1984
- Prolongation of cardiac refractory times in man by clofilium phosphate, a new antiarrhythmic agentAmerican Heart Journal, 1983
- Cellular Electrophysiology of Clofilium, a New Antifibrillatory Agent, in Normal and Ischemic Canine Purkinje FibersJournal of Cardiovascular Pharmacology, 1981
- Clofilium1--a new antifibrillatory agent that selectively increases cellular refractorinessLife Sciences, 1979